181 related articles for article (PubMed ID: 38388957)
1. From Qualitative Research to Quantitative Preference Elicitation: An Example in Invasive Meningococcal Disease.
Coulter J; Whichello C; Heidenreich S; Hauber B; Michaels-Igbokwe C; Cappelleri JC; Peyrani P; Vespa Presa J; Venkatraman M; Schley K
Patient; 2024 May; 17(3):319-333. PubMed ID: 38388957
[TBL] [Abstract][Full Text] [Related]
2. Parental awareness and utilization of meningococcal serogroup B vaccines in the United States.
Srivastava A; Dempsey A; Galitsky A; Fahimi M; Huang L
BMC Public Health; 2020 Jul; 20(1):1109. PubMed ID: 32664872
[TBL] [Abstract][Full Text] [Related]
3. Adolescent, parent and societal preferences and willingness to pay for meningococcal B vaccine: A Discrete Choice Experiment.
Marshall HS; Chen G; Clarke M; Ratcliffe J
Vaccine; 2016 Jan; 34(5):671-677. PubMed ID: 26740249
[TBL] [Abstract][Full Text] [Related]
4. A review of the immunogenicity, safety and current recommendations for the meningococcal serogroup B vaccine, MenB-FHbp.
Burman C; Alderfer J; Snow VT
J Clin Pharm Ther; 2020 Apr; 45(2):270-281. PubMed ID: 31820483
[TBL] [Abstract][Full Text] [Related]
5. Modeling the public health impact of different meningococcal vaccination strategies with 4CMenB and MenACWY versus the current toddler MenACWY National Immunization Program in Chile.
Graña MG; Cavada G; Vasquez M; Shen J; Maervoet J; Klint J; Gómez JA
Hum Vaccin Immunother; 2021 Dec; 17(12):5603-5613. PubMed ID: 34890520
[TBL] [Abstract][Full Text] [Related]
6. Cost-effectiveness of meningococcal polysaccharide serogroups A, C, W-135 and Y conjugate vaccine in Australian adolescents.
Si S; Zomer E; Fletcher S; Lee J; Liew D
Vaccine; 2019 Aug; 37(35):5009-5015. PubMed ID: 31301916
[TBL] [Abstract][Full Text] [Related]
7. Epidemiology of vaccine-preventable invasive diseases in Catalonia in the era of conjugate vaccines.
Ciruela P; Martínez A; Izquierdo C; Hernández S; Broner S; Muñoz-Almagro C; Domínguez À;
Hum Vaccin Immunother; 2013 Mar; 9(3):681-91. PubMed ID: 23303166
[TBL] [Abstract][Full Text] [Related]
8. Invasive meningococcal disease in older adults in North America and Europe: is this the time for action? A review of the literature.
Guedes S; Bertrand-Gerentes I; Evans K; Coste F; Oster P
BMC Public Health; 2022 Feb; 22(1):380. PubMed ID: 35197024
[TBL] [Abstract][Full Text] [Related]
9. Understanding barriers to vaccination against invasive meningococcal disease: a survey of the knowledge gap and potential solutions.
Ballalai I; Dawson R; Horn M; Smith V; Bekkat-Berkani R; Soumahoro L; Vicic N
Expert Rev Vaccines; 2023; 22(1):457-467. PubMed ID: 37144283
[TBL] [Abstract][Full Text] [Related]
10. Impact of an Immunization Campaign to Control an Increased Incidence of Serogroup B Meningococcal Disease in One Region of Quebec, Canada.
De Wals P; Deceuninck G; Lefebvre B; Tsang R; Law D; De Serres G; Gilca V; Gilca R; Boulianne N
Clin Infect Dis; 2017 May; 64(9):1263-1267. PubMed ID: 28207068
[TBL] [Abstract][Full Text] [Related]
11. Impact of routine immunization using meningococcal C conjugate vaccine on invasive meningococcal disease in British Columbia.
Siu T; Tang W; Dawar M; Patrick DM
Can J Public Health; 2008; 99(5):380-2. PubMed ID: 19009920
[TBL] [Abstract][Full Text] [Related]
12. Meningococcal disease and vaccination: Knowledge and acceptability among adolescents in Italy.
Pelullo CP; Napolitano F; Di Giuseppe G
Hum Vaccin Immunother; 2018 May; 14(5):1197-1202. PubMed ID: 29452028
[TBL] [Abstract][Full Text] [Related]
13. Laboratory-confirmed invasive meningococcal disease: effect of the Hajj vaccination policy, Saudi Arabia, 1995 to 2011.
Memish Z; Al Hakeem R; Al Neel O; Danis K; Jasir A; Eibach D
Euro Surveill; 2013 Sep; 18(37):. PubMed ID: 24079399
[TBL] [Abstract][Full Text] [Related]
14. [Invasive meningococcal disease in the Czech Republic - analysis of the epidemiological situation and vaccination strategy recommendations].
Křížová P; Vacková Z; Musílek M; Kozáková J
Epidemiol Mikrobiol Imunol; 2013 Dec; 62(4):138-47. PubMed ID: 24467175
[TBL] [Abstract][Full Text] [Related]
15. Attributes development for a discrete choice experiment on preferences in sexual and reproductive health services for adolescents and young people in Nigeria.
Arije O; Madan J; Hlungwani T
BMC Health Serv Res; 2022 Dec; 22(1):1511. PubMed ID: 36510202
[TBL] [Abstract][Full Text] [Related]
16. Parental Knowledge about Meningococcal Disease and Vaccination Uptake among 0⁻5 years Old Polish Children.
Drozd-Dąbrowska M; Topczewska K; Korzeń M; Sałacka A; Ganczak M
Int J Environ Res Public Health; 2019 Jan; 16(2):. PubMed ID: 30669259
[TBL] [Abstract][Full Text] [Related]
17. Invasive meningococcal disease epidemiology and control measures: a framework for evaluation.
Caro JJ; Möller J; Getsios D; Coudeville L; El-Hadi W; Chevat C; Nguyen VH; Caro I
BMC Public Health; 2007 Jun; 7():130. PubMed ID: 17603880
[TBL] [Abstract][Full Text] [Related]
18. Genomic epidemiology of age-associated meningococcal lineages in national surveillance: an observational cohort study.
Hill DM; Lucidarme J; Gray SJ; Newbold LS; Ure R; Brehony C; Harrison OB; Bray JE; Jolley KA; Bratcher HB; Parkhill J; Tang CM; Borrow R; Maiden MC
Lancet Infect Dis; 2015 Dec; 15(12):1420-8. PubMed ID: 26515523
[TBL] [Abstract][Full Text] [Related]
19. Invasive meningococcal disease in South-Eastern European countries: Do we need to revise vaccination strategies?
Tzanakaki G; Cabrnochová H; Delić S; Draganescu A; Hilfanova A; Onozó B; Pokorn M; Skoczyńska A; Tešović G
Hum Vaccin Immunother; 2024 Dec; 20(1):2301186. PubMed ID: 38173392
[TBL] [Abstract][Full Text] [Related]
20. Meningococcal vaccination: a discussion with all adolescents, whether college-bound or not.
Alderfer JT; Moran MM; Srivastava A; Isturiz RE
Postgrad Med; 2019 Nov; 131(8):551-554. PubMed ID: 31575310
[No Abstract] [Full Text] [Related]
[Next] [New Search]
